BMRA Valuation
Biomerica Inc
$
2.460
BMRA Relative Valuation
BMRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BMRA is overvalued; if below, it's undervalued.
Historical Valuation
Biomerica Inc (BMRA) is now in the Fair zone, suggesting that its current forward PS ratio of 2.46 is considered Fairly compared with the five-year average of 10.41. The fair price of Biomerica Inc (BMRA) is between 0.72 to 4.60 according to relative valuation methord.
Relative Value
Fair Zone
0.72-4.60
Current Price：2.46
Fair
0.79
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Biomerica Inc. (BMRA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 1.64. The thresholds are as follows: Strongly Undervalued below -9.81, Undervalued between -9.81 and -4.09, Fairly Valued between 7.36 and -4.09, Overvalued between 7.36 and 13.09, and Strongly Overvalued above 13.09. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.91
EV/EBIT
Biomerica Inc. (BMRA) has a current EV/EBIT of 0.91. The 5-year average EV/EBIT is 11.16. The thresholds are as follows: Strongly Undervalued below -59.47, Undervalued between -59.47 and -24.15, Fairly Valued between 46.47 and -24.15, Overvalued between 46.47 and 81.79, and Strongly Overvalued above 81.79. The current Forward EV/EBIT of 0.91 falls within the Historic Trend Line -Fairly Valued range.
2.46
PS
Biomerica Inc. (BMRA) has a current PS of 2.46. The 5-year average PS is 2.71. The thresholds are as follows: Strongly Undervalued below -2.14, Undervalued between -2.14 and 0.29, Fairly Valued between 5.14 and 0.29, Overvalued between 5.14 and 7.56, and Strongly Overvalued above 7.56. The current Forward PS of 2.46 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Biomerica Inc. (BMRA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.42. The thresholds are as follows: Strongly Undervalued below -14.54, Undervalued between -14.54 and -7.06, Fairly Valued between 7.91 and -7.06, Overvalued between 7.91 and 15.39, and Strongly Overvalued above 15.39. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Biomerica Inc. (BMRA) has a current P/FCF of 0.00. The 5-year average P/FCF is 1.12. The thresholds are as follows: Strongly Undervalued below -110.99, Undervalued between -110.99 and -54.94, Fairly Valued between 57.17 and -54.94, Overvalued between 57.17 and 113.22, and Strongly Overvalued above 113.22. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Biomerica Inc (BMRA) has a current Price-to-Book (P/B) ratio of 1.34. Compared to its 3-year average P/B ratio of 2.25 , the current P/B ratio is approximately -40.25% higher. Relative to its 5-year average P/B ratio of 3.68, the current P/B ratio is about -63.46% higher. Biomerica Inc (BMRA) has a Forward Free Cash Flow (FCF) yield of approximately -38.13%. Compared to its 3-year average FCF yield of -45.29%, the current FCF yield is approximately -15.82% lower. Relative to its 5-year average FCF yield of -29.26% , the current FCF yield is about 30.32% lower.
1.34
P/B
Median3y
2.25
Median5y
3.68
-38.13
FCF Yield
Median3y
-45.29
Median5y
-29.26
Competitors Valuation Multiple
The average P/S ratio for BMRA's competitors is 2.13, providing a benchmark for relative valuation. Biomerica Inc Corp (BMRA) exhibits a P/S ratio of 2.46, which is 15.53% above the industry average. Given its robust revenue growth of -23.63%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BMRA decreased by 21.05% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.81 to -1.64.
The secondary factor is the Revenue Growth, contributed -23.63%to the performance.
Overall, the performance of BMRA in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Biomerica Inc (BMRA) currently overvalued or undervalued?
Biomerica Inc (BMRA) is now in the Fair zone, suggesting that its current forward PS ratio of 2.46 is considered Fairly compared with the five-year average of 10.41. The fair price of Biomerica Inc (BMRA) is between 0.72 to 4.60 according to relative valuation methord.
What is Biomerica Inc (BMRA) fair value?
How does BMRA's valuation metrics compare to the industry average?
What is the current P/B ratio for Biomerica Inc (BMRA) as of Nov 10 2025?
What is the current FCF Yield for Biomerica Inc (BMRA) as of Nov 10 2025?
What is the current Forward P/E ratio for Biomerica Inc (BMRA) as of Nov 10 2025?